Arch Pharmalabs

1.  In the opinion of the Board, carrying value of all current assets,
 loans & advances and other receivable are not less than their
 realisable value in the ordinary course of business.
 
 2.  Contingent Liabilities not provided for
 
                                                          (Rs. in Lakhs)
 Particulars                                                  As at
                                                            31.03.2008
 
 a) Guarantees given by banks                                   67.77
 b) Letters of Credit                                          272.09
 c) Excise/Customs demands made                                  9.76
 by the Authorities but in respect
 of which appeal have been filed
 
 3.  The company has one segment of activity namely Pharmaceuticals.
 
 4.  In the absence of necessary information with the company relating
 to information to the registration status of suppliers under the Micro,
 Small and Medium Enterprises Development Act, 2006, the information
 required under the said Act could not be compiled and disclosed. The
 Company has not received information from vendors regarding their
 status under the Micro, Small and Medium Enterprises.
 
 5.  Research & Product Development Costs
 
 Research costs which is of revenue nature, is charged to revenue, while
 capital expenditure is included in the respective heads under fixed
 assets.
 
 6.  Previous year figures have been regrouped, reclassified and recast
 wherever necessary to confirm to current years classification.